OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
418360

Mitsui Chemicals Inc

Commodity ChemicalsVerified

Mitsui Chemicals Inc has a debt-to-equity ratio of 0.87, indicating a moderate level of leverage, and a current ratio of 1.72, suggesting reasonable short-term liquidity. However, the company's free cash flow is negative at -23.58 billion JPY, and capital expenditures are substantial at -138.41 billion JPY, indicating significant reinvestment in operations. The company's liquidity position is assessed as medium risk, with net cash being negative after subtracting total debt. In terms of profitability, Mitsui Chemicals Inc reported a return on equity (ROE) of 3.8% and a return on assets (ROA) of 1.5%. These figures are below the typical thresholds for strong performance in the Commodity Chemicals industry, suggesting that the company is generating relatively modest returns on its equity and asset base. The operating margin, calculated as operating income of 78.34 billion JPY on revenue of 1.81 trillion JPY, is 4.33%, which is in line with the industry median for commodity chemical producers. The company's revenue is primarily concentrated in Japan, with a significant portion derived from the domestic market. Mitsui Chemicals Inc's exposure to the Japanese economy makes it sensitive to domestic demand fluctuations and regulatory changes. The company's geographic concentration is a key risk factor, as it limits diversification and exposes the business to regional economic downturns. Looking ahead, Mitsui Chemicals Inc is expected to maintain a stable revenue trajectory, with analysts forecasting a mean price target of 2,211.15 JPY and a median price target of 2,240.00 JPY. The company's revenue growth is anticipated to be modest, with a mean recommendation of 2.50 from analysts, indicating a mixed outlook between buy and hold. The company's capital expenditures are expected to remain high, reflecting ongoing investments in production capacity and technology to maintain competitiveness in the commodity chemicals market. The risk assessment for Mitsui Chemicals Inc highlights a medium liquidity risk and a low dilution risk. The company's liquidity position is constrained by its negative net cash position, which could limit its ability to respond to short-term financial obligations without additional financing. However, the dilution risk is low, as the company has not issued new shares recently, and there are no indications of imminent share dilution through secondary offerings or employee stock options. Recent events, including the company's financial performance and analyst estimates, suggest a cautious outlook for Mitsui Chemicals Inc. The company's operating cash flow of 200.50 billion JPY indicates strong cash generation from operations, but the negative free cash flow suggests that capital expenditures are outpacing cash inflows. The company's ability to maintain or improve its profitability will depend on its capacity to manage costs and optimize production efficiency in a competitive market.

30-day price · 4183+125.00 (+6.5%)
Low$1856.50High$2181.50Close$2038.00As of21 May, 00:00 UTC
Profile
CompanyMitsui Chemicals Inc
Ticker4183.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Mitsui Chemicals Inc is a Japanese chemical company that produces and sells a wide range of commodity chemicals, including petrochemicals, plastics, and synthetic resins, primarily serving the automotive, electronics, and construction industries.

Classification. Mitsui Chemicals Inc is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Mitsui Chemicals Inc has a debt-to-equity ratio of 0.87, indicating a moderate level of leverage, and a current ratio of 1.72, suggesting reasonable short-term liquidity. However, the company's free cash flow is negative at -23.58 billion JPY, and capital expenditures are substantial at -138.41 billion JPY, indicating significant reinvestment in operations. The company's liquidity position is assessed as medium risk, with net cash being negative after subtracting total debt. In terms of profitability, Mitsui Chemicals Inc reported a return on equity (ROE) of 3.8% and a return on assets (ROA) of 1.5%. These figures are below the typical thresholds for strong performance in the Commodity Chemicals industry, suggesting that the company is generating relatively modest returns on its equity and asset base. The operating margin, calculated as operating income of 78.34 billion JPY on revenue of 1.81 trillion JPY, is 4.33%, which is in line with the industry median for commodity chemical producers. The company's revenue is primarily concentrated in Japan, with a significant portion derived from the domestic market. Mitsui Chemicals Inc's exposure to the Japanese economy makes it sensitive to domestic demand fluctuations and regulatory changes. The company's geographic concentration is a key risk factor, as it limits diversification and exposes the business to regional economic downturns. Looking ahead, Mitsui Chemicals Inc is expected to maintain a stable revenue trajectory, with analysts forecasting a mean price target of 2,211.15 JPY and a median price target of 2,240.00 JPY. The company's revenue growth is anticipated to be modest, with a mean recommendation of 2.50 from analysts, indicating a mixed outlook between buy and hold. The company's capital expenditures are expected to remain high, reflecting ongoing investments in production capacity and technology to maintain competitiveness in the commodity chemicals market. The risk assessment for Mitsui Chemicals Inc highlights a medium liquidity risk and a low dilution risk. The company's liquidity position is constrained by its negative net cash position, which could limit its ability to respond to short-term financial obligations without additional financing. However, the dilution risk is low, as the company has not issued new shares recently, and there are no indications of imminent share dilution through secondary offerings or employee stock options. Recent events, including the company's financial performance and analyst estimates, suggest a cautious outlook for Mitsui Chemicals Inc. The company's operating cash flow of 200.50 billion JPY indicates strong cash generation from operations, but the negative free cash flow suggests that capital expenditures are outpacing cash inflows. The company's ability to maintain or improve its profitability will depend on its capacity to manage costs and optimize production efficiency in a competitive market.
Key takeaways
  • Mitsui Chemicals Inc has a moderate debt-to-equity ratio of 0.87 and a current ratio of 1.72, indicating a balanced capital structure but limited liquidity flexibility.
  • The company's ROE of 3.8% and ROA of 1.5% are below industry benchmarks, suggesting suboptimal returns on equity and assets.
  • Mitsui Chemicals Inc's revenue is heavily concentrated in Japan, exposing it to regional economic and regulatory risks.
  • Analysts project a mixed outlook for the company, with a mean price target of 2,211.15 JPY and a median price target of 2,240.00 JPY.
  • The company's liquidity risk is medium, and its dilution risk is low, with no recent share issuance activity.
  • Mitsui Chemicals Inc's capital expenditures are expected to remain high, reflecting ongoing investments in production capacity and technology.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$1.81T
Gross profit$388.29B
Operating income$78.34B
Net income$32.24B
R&D
SG&A
D&A
SBC
Operating cash flow$200.50B
CapEx-$138.41B
Free cash flow-$23.58B
Total assets$2.15T
Total liabilities$1.31T
Total equity$848.28B
Cash & equivalents$167.51B
Long-term debt$737.98B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$848.28B
Net cash-$570.47B
Current ratio1.7
Debt/Equity0.9
ROA1.5%
ROE3.8%
Cash conversion6.2%
CapEx/Revenue-7.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4183Activity
Op margin4.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.8%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin21.5%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity87.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target2,211.15 JPY
Median price target2,240.00 JPY
High price target3,000.00 JPY
Low price target1,550.00 JPY
Mean recommendation2.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count6.00
Hold count6.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate116.93 JPY
Last actual EPS85.28 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-24 17:34 UTCJob: dafe15b8